Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition, including a notice that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T01:49:30.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T01:39:16.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s site revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T02:04:10.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The study details page now displays a 403 Forbidden error, blocking access to the content.
    Difference
    0.5%
    Check dated 2026-09-27T01:50:51.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record details, indicating access to the record is blocked. The visible changes consist of the 403 message, header, and footer rather than the study content, signaling an access issue rather than an update to the study data.
    Difference
    21%
    Check dated 2026-09-20T00:54:41.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page footer now shows revision v3.6.6, replacing the previous v3.6.5 and signaling a recent update to the record.
    Difference
    0.0%
    Check dated 2026-08-29T20:07:35.000Z thumbnail image

Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.